AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.63
-0.14 (-2.43%)
At close: Oct 28, 2025, 4:00 PM EDT
5.62
-0.01 (-0.18%)
Pre-market: Oct 29, 2025, 4:44 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.68 billion as of October 28, 2025. Its market cap has increased by 128.38% in one year.
Market Cap
1.68B
Enterprise Value
1.27B
1-Year Change
128.38%
Ranking
Category
Stock Price
$5.63
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.68B, a decrease of -89.26%. That is a compound annual growth rate of -36.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 1.72B | 99.24% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
| Dec 11, 2020 | 15.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |